|
1
|
Liggett T, Melnikov A, Yi QL, Replogle C,
Brand R, Kaul K, Talamonti M, Abrams RA and Levenson V:
Differential methylation of cell-free circulating DNA among
patients with pancreatic cancer versus chronic pancreatitis.
Cancer. 116:1674–1680. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kahlert C, Weber H, Mogler C, Bergmann F,
Schirmacher P, Kenngott HG, Matterne U, Mollberg N, Rahbari NN,
Hinz U, et al: Increased expression of ALCAM/CD166 in pancreatic
cancer is an independent prognostic marker for poor survival and
early tumour relapse. Br J Cancer. 101:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arcidiacono PG, Bhutani MS and Giovannini
M: EURO-EUS 2003: Pancreatic tumor: Impact of endoscopic
ultrasonography on diagnosis, staging and treatment. Cancer Biol
Ther. 3:477–481. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mcgough N and Cummings JH: Coeliac
disease: A diverse clinical syndrome caused by intolerance of
wheat, barley and rye. Proc Nut Soc. 64:434–450. 2005. View Article : Google Scholar
|
|
5
|
Garcea G, Dennison AR, Pattenden CJ, Neal
CP, Sutton CD and Berry DP: Survival following curative resection
for pancreatic ductal adenocarcinoma. A systematic review of the
literature. JOP. 9:99–132. 2008.PubMed/NCBI
|
|
6
|
Martin RC II, Kwon D, Chalikonda S,
Sellers M, Kotz E, Scoggins C, McMasters KM and Watkins K:
Treatment of 200 locally advanced (stage III) pancreatic
adenocarcinoma patients with irreversible electroporation: Safety
and efficacy. Ann Surg. 262:486–494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu J and Chen Q: Antitumor activities of
rauwolfia vomitoria extract and potentiation of gemcitabine effects
against pancreatic cancer. Integr Cancer Ther. 13:217–225. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mccarroll J, Teo J, Boyer C, Goldstein D,
Kavallaris M and Phillips PA: Potential applications of
nanotechnology for the diagnosis and treatment of pancreatic
cancer. Front Physiol. 5:22014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clini. 63:318–348. 2013. View Article : Google Scholar
|
|
10
|
Hussain SP: Pancreatic cancer: Current
progress and future challenges. Int J Biol Sci. 12:270–272. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wasmeier C, Romao M, Plowright L, Bennett
DC, Raposo G and Seabra MC: Rab38 and Rab32 control post-Golgi
trafficking of melanogenic enzymes. J Cell Biol. 175:271–281. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chan AM and Weber T: A putative link
between exocytosis and tumor development. Cancer Cell. 2:427–428.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hutagalung AH and Novick PJ: Role of Rab
GTPases in membrane traffic and cell physiology. Physiol Rev.
91:119–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grosshans BL, Ortiz D and Novick P: Rabs
and their effectors: Achieving specificity in membrane traffic.
Proc Nati Acad Sci USA. 103:11821. 2006. View Article : Google Scholar
|
|
15
|
Osanai K, Higuchi J, Oikawa R, Kobayashi
M, Tsuchihara K, Iguchi M, Huang J, Voelker DR and Toga H: Altered
lung surfactant system in a Rab38-deficient rat model of
Hermansky-Pudlak syndrome. Am J Physiol Lung Cell Mol Physiol.
298:243–251. 2010. View Article : Google Scholar
|
|
16
|
Osanai K, Takahashi K, Nakamura K,
Takahashi M, Ishigaki M, Sakuma T, Toga H, Suzuki T and Voelker DR:
Expression and characterization of Rab38, a new member of the Rab
small G protein family. Biol Chem. 386:143–153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H and Jiang C: Rab38 confers a poor
prognosis, associated with malignant progression and subtype
preference in glioma. Oncol Rep. 30:2350–2356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bultema JJ and Di PSM: Cell type-specific
Rab32 and Rab38 cooperate with the ubiquitous lysosome biogenesis
machinery to synthesize specialized lysosome-related organelles.
Small Gtpases. 4:16–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lopes VS, Wasmeier C, Seabra MC and Futter
CE: Melanosome maturation defect in Rab38-deficient retinal pigment
epithelium results in instability of immature melanosomes during
transient melanogenesis. Mol Biol Cell. 18:3914–3927. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jäger D, Stockert E, Jäger E, Güre AO,
Scanlan MJ, Knuth A, Old LJ and Chen YT: Serological cloning of a
melanocyte rab guanosine 5′-triphosphate-binding protein and a
chromosome condensation protein from a melanoma complementary DNA
library. Cancer Res. 60:3584–3591. 2000.PubMed/NCBI
|
|
21
|
Abdelmonsef AH, Dulapalli R, Dasari T,
Padmarao LS, Mukkera T and Vuruputuri U: Structure based drug
discovery of Rab38 protein-identification of antagonists as cancer
drug candidates. Comb Chem High Throughput Screen. 19:875–892.
2016.PubMed/NCBI
|
|
22
|
Na L, Tang B, Zhu ED, Li BS, Zhuang Y, Yu
S, Lu DS, Zou QM, Xiao B and Mao XH: Increased miR-222 in H.
pylori-associated gastric cancer correlated with tumor progression
by promoting cancer cell proliferation and targeting RECK. FEBS
Lett. 586:722–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moffat J, Grueneberg DA, Yang X, Kim SY,
Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK,
et al: A lentiviral RNAi library for human and mouse genes applied
to an arrayed viral high-content screen. Cell. 124:1283–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu E, Wang X, Zheng B, Wang Q, Hao J,
Chen S, Zhao Q, Zhao L, Wu Z and Yin Z: miR-20b suppresses Th17
differentiation and the pathogenesis of experimental autoimmune
encephalomyelitis by targeting RORgammat and STAT3. J Immunol.
192:5599–5609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and and Schmittgen TD: Analysis
of relative gene expression data using real-time quantitative PCR
and the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han S, Jin G, Wang L, Li M, He C, Guo X
and Zhu Q: The role of PAM4 in the management of pancreatic cancer:
Diagnosis, radioimmunodetection, and radioimmunotherapy. J Immunol
Res. 2014:2684792014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buscarini E, Pezzilli R, Cannizzaro R, De
Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G,
Barresi L, et al: Italian consensus guidelines for the diagnostic
work-up and follow-up of cystic pancreatic neoplasms. Dig Liver
Dis. 46:479–493. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Herrmann P, Huber S, Hesler CV, Tischer A,
Luckner M, Bruns C and Heeschen C: Identification and
characterization of highly metastatic and therapy resistant tumor
stem cells in pancreatic cancer. Cancer Res. 67:1292. 2007.
|
|
29
|
Osanai K, Iguchi M, Takahashi K, Nambu Y,
Sakuma T, Toga H, Ohya N, Shimizu H, Fisher JH and Voelker DR:
Expression and localization of a novel Rab small G protein (Rab38)
in the rat lung. Am J Pathol. 158:1665–1675. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ninkovic I, White JG, Rangelfilho A and
Datta YH: The role of Rab38 in platelet dense granule defects. J
Thromb Haemost. 6:2143–2151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Walton SM, Gerlinger M, de la Rosa O,
Nuber N, Knights A, Gati A, Laumer M, Strauss L, Exner C, Schäfer
N, et al: Spontaneous CD8 T cell responses against the melanocyte
differentiation antigen RAB38/NY-MEL-1 in melanoma patients. J
Immunol. 177:8212–8218. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abdelmonsef AH, Dulapalli R, Dasari T,
Padmarao LS, Mukkera T and Vuruputuri U: Identification of novel
antagonists for Rab38 protein by homology modeling and virtual
screening. Comb Chem High Throughput Screen. 19:875–892. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He AR and Goldenberg AS: Treating
hepatocellular carcinoma progression following first-line
sorafenib: Therapeutic options and clinical observations. Therap
Adv Gastroenterol. 6:447–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hicks J, Krasnitz A, Lakshmi B, Navin NE,
Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, et
al: Novel patterns of genome rearrangement and their association
with survival in breast cancer. Genome Res. 16:1465–1479. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Borowa-Mazgaj B: Pancreatic
cancer-mechanisms of chemoresistance. Postepy Hig Med Dosw
(Online). 70:169–179. 2016.(In Polish). View Article : Google Scholar : PubMed/NCBI
|
